ICICI Prudential Mutual Fund
Up to one year: absolute. Longer: annualised. Category = median of Other ETF -plan Growth funds.
| Period | This fund | Category median | Rank in category |
|---|---|---|---|
| 1 month | -3.47% | -5.90% | — |
| 3 months | +0.37% | -5.04% | — |
| 6 months | +14.75% | +3.02% | — |
| 1 year | +12.79% | -0.61% | #12 of 101 Top 12% |
| 3 years | +18.76% | +7.35% | #5 of 50 Top 10% |
| 5 years | +12.81% | +6.23% | #2 of 16 Top 13% |
| 10 years | — | +11.20% | — |
| Since launch of NAV data | +13.50% | — | — |
| Window | High | Low |
|---|---|---|
| 1 month | 173.1734 | 165.2130 |
| 3 months | 173.9420 | 164.6049 |
| 6 months | 173.9420 | 142.7286 |
| 1 year | 173.9420 | 141.0256 |
A period is a dash when the fund has not existed that long or its NAV history has a hole at the start date — never a partial figure.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | YTD | |
|---|---|---|---|---|---|---|---|
| This fund | — | — | -10.19% | +33.76% | +41.13% | -1.62% | +10.34% |
| Category median | +15.70% | +23.03% | +4.44% | +21.29% | +12.36% | +9.19% | -5.01% |
Twenty checks of five points each: performance, portfolio, operations, and risk against reward. Only checks we have data for are counted.
Risk-free rate 6.06% (3-year annualised return of the NSE 1-day (overnight) rate index). This category has no reference index in our data, so benchmark-relative ratios are not shown.
| Ratio | This fund | Category median | Against category |
|---|---|---|---|
| Sharpe ratio | 0.86 | 0.19 | Better |
| Sortino ratio | 1.23 | 0.27 | Better |
| Standard deviation | 14.73% | 13.98% | Worse |
| Maximum drawdown | -15.70% | -18.09% | Better |
| Beta | — | 1.00 | — |
| R-squared | — | 100.0% | — |
| Jensen's alpha | — | -0.26% | — |
| Treynor ratio | — | 1.79 | — |
| Information ratio | — | -3.20 | — |
| Upside capture | — | 99.8% | — |
| Downside capture | — | 100.0% | — |
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| Equity & Equity Related Instruments | — | 99.99% | — | — |
| Listed / Awaiting Listing On Stock Exchanges | — | 99.99% | — | — |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 18.08% | — | 143.5 |
| Divi's Laboratories Ltd. | Healthcare | 10.35% | — | 83.0 |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 7.88% | — | 73.1 |
| Cipla Ltd. | Healthcare | 6.82% | — | 35.1 |
| MAX Healthcare Institute Ltd | Healthcare | 6.67% | — | 124.3 |
| Laurus Labs Ltd. | Healthcare | 6.41% | — | 122.0 |
| Torrent Pharmaceuticals Ltd. | Healthcare | 6.39% | — | 77.7 |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 6.05% | — | 150.9 |
| Lupin Ltd. | Healthcare | 4.57% | — | 13.2 |
| Aurobindo Pharma Ltd. | Healthcare | 4.09% | — | 37.5 |
| Fortis Healthcare Ltd. | Healthcare | 4.07% | — | 255.5 |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 3.21% | — | 316.1 |
| Alkem Laboratories Ltd. | Healthcare | 2.68% | — | 29.1 |
| Biocon Ltd. | Healthcare | 2.53% | — | 596.5 |
| Zydus Lifesciences Ltd. | Healthcare | 2.50% | — | 32.6 |
| IPCA Laboratories Ltd. | Healthcare | 2.36% | — | 39.8 |
| Mankind Pharma Ltd. | Healthcare | 2.36% | — | 46.9 |
| Abbott India Ltd. | Healthcare | 1.16% | — | 34.5 |
| Piramal Pharma Ltd. | Healthcare | 1.15% | — | 37.0 |
| Syngene International Ltd. | Healthcare | 0.66% | — | 62.8 |
| Net Current Assets | — | 0.01% | — | — |
This is a paid feature
Comparing more months of this fund's own portfolio history is available on paid plans.
Sign inExpense ratio by month: Oct 25 0.15% · Nov 25 0.15% · Dec 25 0.15% · Jan 26 0.15% · Feb 26 0.15% · Mar 26 0.15% · Apr 26 0.15% · May 26 0.15% · Jun 26 0.15% · Jul 26 0.15% · Aug 26 0.17% · Sep 26 0.16%
Nil
The investment objective of the scheme is to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors.; However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
